loading
Überblick Nachrichten Preisverlauf Financials Forum Prognose
Schlusskurs vom Vortag:
$1.1797
Offen:
$1.14
24-Stunden-Volumen:
7,565
Relative Volume:
0.01
Marktkapitalisierung:
$45.60M
Einnahmen:
$13.42M
Nettoeinkommen (Verlust:
$-73.35M
KGV:
-0.5833
EPS:
-1.92
Netto-Cashflow:
$-56.34M
1W Leistung:
-5.08%
1M Leistung:
-26.80%
6M Leistung:
+15.46%
1J Leistung:
-12.50%
1-Tages-Spanne:
Value
$1.11
$1.1991
1-Wochen-Bereich:
Value
$1.11
$1.33
52-Wochen-Spanne:
Value
$0.64
$2.92

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile

Name
Firmenname
Barinthus Biotherapeutics Plc Adr
Name
Sektor
Healthcare (1145)
Name
Branche
Biotechnology (641)
Name
Telefon
44 (0) 1865 818808
Name
Adresse
20400 CENTURY BLVD, GERMANTOWN
Name
Mitarbeiter
105
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
BRNS's Discussions on Twitter

Vergleichen Sie BRNS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BRNS
Barinthus Biotherapeutics Plc Adr
 1.12 48.04M 13.42M -73.35M -56.34M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
 712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 306.05 35.42B 3.81B -644.79M -669.77M -6.24

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-05-25 Eingeleitet Jefferies Buy
2021-05-25 Eingeleitet Morgan Stanley Overweight
2021-05-25 Eingeleitet William Blair Outperform
2021-05-24 Eingeleitet H.C. Wainwright Buy

Barinthus Biotherapeutics Plc Adr Aktie (BRNS) Neueste Nachrichten

pulisher
Jul 16, 2025

BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com

Jul 16, 2025
pulisher
Apr 01, 2025

BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com

Apr 01, 2025
pulisher
Jan 31, 2025

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - Nasdaq

Jan 31, 2025
pulisher
Jan 10, 2025

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

Jan 10, 2025
pulisher
Dec 04, 2024

The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice

Dec 04, 2024
pulisher
Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024
pulisher
Sep 03, 2024

Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research

Sep 03, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Investing.com UK

Jun 21, 2024
pulisher
Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024
pulisher
Nov 21, 2017

Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat

Nov 21, 2017

Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie BRNS

biotechnology GMAB
$24.87
price down icon 0.96%
biotechnology INCY
$84.61
price up icon 1.09%
biotechnology SMMT
$23.70
price down icon 2.95%
biotechnology BNTX
$100.00
price down icon 1.89%
biotechnology INSM
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):